...
【24h】

Action mechanism of Yi Guan Jian Decoction on CCl(4) induced cirrhosis in rats.

机译:益冠健汤对CCl(4)所致大鼠肝硬化的作用机制。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM OF STUDY: To investigate action mechanism of Yi Guan Jian Decoction on cirrhosis induced by CCl(4) in rats. MATERIAL AND METHODS: CCl(4) (3mL/kg) for the first time and then olive oil CCl(4) solution 50% (2mL/kg) was administered hypodermically to rats twice each week for 12 weeks. At the end of 8th week, rats were randomly divided into CCl(4) control group (n=10), Yi Guan Jian Decoction group (n=9) and Xiao Chai Hu Decoction group (n=9). Yi Guan Jian Decoction and Xiao Chai Hu Decoction were oral administrated per day respectively for 4 weeks, concomitantly continued CCl(4) administration. At 12th weekend, the rats were sacrificed for sampling and detection of liver function, histological changes of liver tissue, liver tissue hydroxyproline content and expression of alpha-SMA, CD68, MMP-13, TIMP-1, TIMP-2, Caspase-12, HGFalpha, MMP-2, MMP-9 and hepatocyte apoptotic index. RESULTS AND CONCLUSIONS: (1) Compared with that of normal rats, expression of alpha-SMA, CD68 and TIMP-1 in liver tissue of 8 week model group rats increases significantly (P<0.01), moreover further increased in the 12 week of model group. However, MMP-13, HGFalpha, TIMP-2 content decreases gradually and the statistical difference is seen between each time point (P<0.01). Activity of MMP-2, MMP-9, content of Caspase-12 and hepatocyte apoptotic index increased gradually at 4th, 8th, 12th week. (2) Compared to that of the same time point model group, activity of MMP-9 and contents of MMP-13, TIMP-2 and HGFalpha in Yi Guan Jian Decoction group improves significantly (P<0.01), and activity of MMP-2 and contents of alpha-SMA, TIMP-1, Caspase-12 and hepatocyte apoptotic index decreases significantly (P<0.01). This work suggests that Yi Guan Jian Decoction exerts significant therapeutic effect on CCl(4)-induced cirrhosis in rats, through mechanism of inhibiting hepatocytes apoptosis and hepatic stellate cells activation, and regulating the function of Kupffer cell. ETHNOPHARMACOLOGICAL RELEVANCE: This study investigates the mechanism of YiGuan Jian against cirrhosis from aspect of heptocytes apoptosis and hepatic stellate cells activation. It suggest that although of unknown bioactive ingredients, mechanism of traditional Chinese medicine recipe against cirrhosis can be disclosed and of profound significance.
机译:研究目的:探讨益冠健汤对CCl(4)所致大鼠肝硬化的作用机制。材料和方法:首次将CCl(4)(3mL / kg)注入皮下,然后每周两次对大鼠皮下注射50%(2mL / kg)的橄榄油CCl(4)溶液,持续12周。在第8周结束时,将大鼠随机分为CCl(4)对照组(n = 10),益冠健汤组(n = 9)和小柴胡汤组(n = 9)。每天分别口服益冠健汤和小柴胡汤4周,并同时持续服用CCl(4)。在第12周末,处死大鼠以取样和检测肝功能,肝组织的组织学变化,肝组织羟脯氨酸含量以及α-SMA,CD68,MMP-13,TIMP-1,TIMP-2,Caspase-12的表达。 ,HGFalpha,MMP-2,MMP-9和肝细胞凋亡指数。结果与结论:(1)与正常大鼠相比,8周模型组大鼠肝脏组织中α-SMA,CD68和TIMP-1的表达明显增加(P <0.01),并且在12周时进一步增加。模型组。然而,MMP-13,HGFalpha,TIMP-2含量逐渐降低,并且在每个时间点之间都具有统计学差异(P <0.01)。 MMP-2,MMP-9的活性,Caspase-12的含量和肝细胞凋亡指数在第4、8、12周逐渐升高。 (2)与官穴模型组相比,益冠健汤组MMP-9活性,MMP-13,TIMP-2和HGFα含量明显提高(P <0.01),MMP-如图2所示,α-SMA,TIMP-1,Caspase-12和肝细胞凋亡指数的含量明显降低(P <0.01)。这项工作表明益冠健汤具有抑制肝细胞凋亡和肝星状细胞活化以及调节库普弗细胞功能的机制,对CCl(4)所致大鼠肝硬化具有显着的治疗作用。人类药理学相关性:本研究从肝细胞凋亡和肝星状细胞激活的角度研究了益肝健对肝硬化的作用机制。这表明,尽管其生物活性成分未知,但可以揭示中医治疗肝硬化的机制,具有重要的意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号